NOI Sole Source.pdf

NOTICE OF INTENT to Sole Source

TITLE:

Service and Maintenance for 2 BD LSR Fortessa Flow Cytometer Systems

CLASSIFICATION CODE:

J066 Maintenance and Repair of Instruments and Laboratory Equipment

NAICS CODE:

811210 – Electronic and Precision Equipment Repair and Maintenance

RESPONSE DATE:

August 19, 2026

PRIMARY POINT OF CONTACT:

Deborah Blyveis, Contract Specialist Office of Acquisition Management Services Office of the Assistant Secretary for Administration U.S. Department of Health and Human Services deborah.blyveis@hhs.gov

DESCRIPTION:

THIS IS A PRE-SOLICITATION NOTICE OF INTENT TO AWARD ON A SOLE SOURCE

BASIS. THIS IS NOT A REQUEST FOR QUOTE/PROPOSALS.

In accordance with the Federal Acquisition Regulations including the provisions set forth in FAR Subpart 5.101(a): the U.S. Department of Health and Human Services (HHS), National Institutes of Health (NIH), National Cancer Institute (NCI), Center for Cancer Research (CCR), Center for Immuno-Oncology (CIO) intends to solicit on a sole-source basis (by a request for quotation to USBDB Service Contract Admin (BD Biosciences)) maintenance services for 2 BD LSR Fortessa Flow Cytometer Systems on or around August 4, 2026 with an award issued on or around August 19, 2026. The purpose of this acquisition is to acquire preventative maintenance and service for two existing BD LSR Fortessa Flow Cytometer Systems that was originally manufactured by BD Biosciences. These maintenance services shall be provided by an Original Equipment Manufacturer (OEM)-Authorized Service Provider of the LSR Fortessa Flow Cytometer, and all maintenance services shall be performed by OEM certified factory-trained technicians using OEM certified parts. In addition, BD Biosciences is the only provider that can supply instrument software revisions. This Sole Source Determination is based on HHS’ determination that BD Biosciences is the only Vendor that provides the required services.

mailto:deborah.blyveis@hhs.gov%20

NORTH AMERICAN INDUSTRY CLASSIFICATION SYSTEM (NAICS) CODE and SET ASIDE

STATUS

The intended procurement is classified under NAICS code 811210 with a Size Standard of $34M.

This acquisition is NOT set aside for small businesses but rather is a sole-source acquisition to BD Biosciences.

BACKGROUND, PURPOSE AND OBJECTIVES OF REQUIREMENT

The U.S. Department of Health and Human Services (HHS), National Institutes of Health (NIH), National Cancer Institute (NCI), Center for Cancer Research (CCR), Center for Immuno-Oncology (CIO) requires maintenance and support for two (2) Government-owned BD LSR Fortessa Flow Cytometer systems. The CIO is involved in the analysis of patient samples pre and post immunotherapy to monitor specific immune responses. The BD LSR Fortessa instruments are a crucial part in the ongoing research effort of the CIO to design and evaluate different forms of cancer immunotherapies.

The CIO continually uses its two (2) LSR Fortessa cytometers to analyze human samples from clinical studies across NCI and other Cancer Centers throughout the United States on a daily basis. Due to the significant number of efforts the CIO supports, the equipment cannot be out of service for any length of time without causing significant delays to research efforts across the organization, and potential financial injury to the Government due to the loss of analytical data from expensive and often irreplaceable clinical samples not being processed in a timely manner. It is essential to maintain and service the 2 BD LSR Fortessa Flow Cytometer systems, with their cutting-edge technology, on a regular maintenance schedule.

Only an OEM-authorized service provider has access to the latest services, manufacturer parts, and support information. Replacement parts or accessories must be compatible with the existing equipment, and only BD Biosciences can certify compatibility. An OEM-authorized service provider is the only source with direct access to these parts and labor.

BD Biosciences is the only source authorized by the OEM to provide maintenance services for this equipment and is the only source for factory trained and certified technicians to maintain and service the equipment.

Only lasers configured by BD Biosciences for use in this instrument can be used without voiding the applicable warranties and ensuring that the system performs as intended.

Use of an OEM-Authorized Service Provider is essential for maintaining the integrity of the system. Thus, BD Biosciences is the only source known to National Cancer Institute to guarantee maintenance and repair and meet the Government’s needs at this time.

The intended source is:

USBDB Service Contract Admin (BD Biosciences) 155 North McCarthy Boulevard Milpitas CA 95035

Estimated Period of Performance:

September 6, 2026 through September 5, 2027

Place of Performance:

National Institutes of Health National Cancer Institute (NCI) 10 Center Drive Bldg 10 Bethesda, MD 20892

Contract Type:

A firm-fixed price type contract is planned for this acquisition, consistent with commercial practices.

CLOSING STATEMENT

THIS NOTICE OF INTENT TO AWARD ON A SOLE-SOURCE BASIS IS NOT A REQUEST FOR

COMPETITIVE PROPOSALS. However, interested parties may identify their interest and capability to respond to this notice.

A determination by the Government not to compete this proposed contract based upon responses to this notice is solely within the discretion of the Government. All responsible sources may submit a capability statement, proposal, or quotation which shall be considered by the agency. The information received will normally be considered solely for the purposes of determining whether to proceed on a non-competitive basis or to conduct a competitive procurement.

Responses to this notice shall contain sufficient information to establish the interested parties' bona-fide capabilities for fulfilling the requirement and include: unit price, list price, shipping and handling costs, the delivery period after contract award, the prompt payment discount terms, the F.O.B. Point (Destination or Origin), the Dun & Bradstreet Number (DUNS), UNIQUE ENTITY ID, the Taxpayer Identification Number (TIN), and the certification of business size. All offerors must have an active registration in the System for Award Management (SAM) www.sam.gov. All responses must provide evidence that they can provide equipment that meets all of the requirements in this announcement.

All responses must be received by the closing date and time of this announcement and must reference the reference number, NIH-NCI-0819. Responses must be submitted https://gcc02.safelinks.protection.outlook.com/?url=http%3A%2F%2Fwww.sam.gov%2F&data=05%7C02%7Cshayna.simpson%40hhs.gov%7Cd8f978301179489a2f2d08de5524c41b%7Cd58addea50534a808499ba4d944910df%7C0%7C0%7C639041813552878109%7CUnknown%7CTWFpbGZsb3d8eyJFbXB0eU1hcGkiOnRydWUsIlYiOiIwLjAuMDAwMCIsIlAiOiJXaW4zMiIsIkFOIjoiTWFpbCIsIldUIjoyfQ%3D%3D%7C0%7C%7C%7C&sdata=1AT13TiG7luY3u%2BYs0igT%2FtKZS98k6yBql1F9s%2FI%2Fm8%3D&reserved=0 electronically to Deborah Blyveis, Contract Specialist, Office of Acquisition Management Services, Office of the Assistant Secretary for Administration U.S. Department of Health and Human Services at deborah.blyveis@hhs.gov. U.S. Mail and Fax responses will not be accepted.

mailto:deborah.blyveis@hhs.gov